findmyKOL
Clinical trialNCT02514629CompletedPhase 3Interventional

Testosterone, Metformin, or Both, for Hypogonadism in Obese Males

SponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludEnrollment107HypogonadismObesity
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jose Carlos Fernandez-Garcia, MD

    Hospital Universitario Virgen de la Victoria. Malaga

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Hospital Uiversitario Virgen de la Victoria

    Málaga, Malaga, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Jul 2013
Primary completion
12 Jul 2016
Completion
12 Jul 2016
Last update posted
13 Dec 2024
Registered enrollment
107
Registry id
NCT02514629

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.